Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chloroprocaine + ropivacaine is a local anesthetic combination therapy utilized for labor analgesia. Chloroprocaine is an ester-type anesthetic characterized by a very rapid onset and short duration of action due to rapid hydrolysis by plasma pseudocholinesterase. Ropivacaine is an amide-type anesthetic that provides long-lasting sensory blockade with minimal motor block and reduced cardiotoxicity compared to bupivacaine. By combining these two agents, clinicians aim to achieve a fast-acting loading dose effect from chloroprocaine followed by the sustained relief provided by ropivacaine. This combination is specifically studied by institutions like Hefei Maternal and Child Health Hospital to improve the management of labor pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chloroprocaine + ropivacaine.